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Abstract
AT-rich DNA, and the proteins that bind it (AT-hook proteins), modulate chromosome structure and function in most
eukaryotes. Unlike other trypanosomatids, the genome of Leishmania species is unusually GC-rich, and the regulation of
Leishmania chromosome structure, replication, partitioning is not fully understood. Because AT-hook proteins modulate
these functions in other eukaryotes, we examined whether AT-hook proteins are encoded in the Leishmania genome, to test
their potential functions. Several Leishmania ORFs predicted to be AT-hook proteins were identified using in silico
approaches based on sequences shared between eukaryotic AT-hook proteins. We have used biochemical, molecular and
cellular techniques to characterize the L. amazonensis ortholog of the L. major protein LmjF06.0720, a potential AT-hook
protein that is highly conserved in Leishmania species. Using a novel fusion between the AT-hook domain encoded by
LmjF06.0720 and a herpesviral protein, we have demonstrated that LmjF06.0720 functions as an AT-hook protein in
mammalian cells. Further, as observed for mammalian and viral AT-hook proteins, the AT-hook domains of LmjF06.0720
bind specific regions of condensed mammalian metaphase chromosomes, and support the licensed replication of DNA in
mammalian cells. LmjF06.0720 is nuclear in Leishmania, and this localization is disrupted upon exposure to drugs that
displace AT-hook proteins from AT-rich DNA. Coincidentally, these drugs dramatically alter the cellular physiology of
Leishmania promastigotes. Finally, we have devised a novel peptido-mimetic agent derived from the sequence of
LmjF06.0720 that blocks the proliferation of Leishmania promastigotes, and lowers amastigote parasitic burden in infected
macrophages. Our results indicate that AT-hook proteins are critical for the normal biology of Leishmania. In addition, we
have described a simple technique to examine the function of Leishmania chromatin-binding proteins in a eukaryotic
context amenable to studying chromosome structure and function. Lastly, we demonstrate the therapeutic potential of
compounds directed against AT-hook proteins in Leishmania.
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Introduction
AT-rich sequences in chromosomal DNA are closely associated
with cellular processes such as DNA replication and transcription
in many eukaryotes. In this context, the genomes of Leishmania sp.
are unusual even amongst other trypanosomatids by virtue of their
high GC-content, as high as 60% in Leishmania major [1]. Despite
this GC-bias, it is apparent there is a skewed distribution of AT-
rich sequences in Leishmania chromosomes. For example, the
strand-switch regions (SSRs) from where transcription initiates
[2,3], are .50% AT-rich [4,5].
In many eukaryotes, a class of proteins, termed AT-hook
proteins, is central to DNA replication, repair and transcription
[6,7,8,9,10,11,12,13]. These proteins contain a motif termed the
AT-hook that binds the minor groove of AT-rich DNA [14]. Their
effector functions result from either inducing conformational
changes in the bound sequences, or from other domains of these
proteins recruiting components of the replication, repair or
transcription pathways. The AT-hook motif is typically a short
repeat of glycine and arginine flanked by a proline at one or both
ends, for example GRGRP, PRGRP, or KRGRP [15]. The
central RGR of the AT-hook inserts into the minor groove of AT-
rich DNA, where there are interactions between arginine and
thymidine [16,17]. The absence of a side-chain on glycine also
facilitates minor groove insertion. In addition to canonical AT-
hooks, other sequences with repeats of glycine and arginine (GR
repeat sequences) can also bind AT-rich DNA. Nucleolin, a
nucleolar protein contains an extended GGR repeat and binds the
T-strand of AT-rich DNA with high affinity [18]. Our previous
studies have shown that the sequence GRGRGRGRGRGGGRP
in the EBNA1 protein of Epstein-Barr virus binds AT-rich DNA
with very high specificity [19].
The prototypic eukaryotic AT-hook protein is the mammalian
HMGA1a protein [14]. This protein contains three AT-hooks. In
mammalian cells, HMGA1a is essential to form transcription
enhanceosomes [10,11], and can recruit the licensed DNA
replication machinery to chromosomal replication origins [9,13].
Indeed, the multi-subunit replication origin recognition complex
(ORC) in budding and fission yeasts also recognizes AT-rich DNA
[7,12]. In fission yeast, the Orc4 subunit of ORC contains nine
AT-hooks (ibid), whereas Orc2 in S. cerevisiae contains one AT-hook
[20]. Although the mammalian ORC proteins do not contain AT-
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ORC to replication origins [9]. A function for AT-hooks in
licensed DNA replication extends to mammalian DNA viruses that
replicate as episomes in infected mammalian cells. For Epstein-
Barr virus (EBV), the viral protein Epstein-Barr nuclear antigen 1
(EBNA1) uses a site-specific DNA-binding domain to bind the
virus replication origin, and AT-hook domains to recruit ORC to
this origin [13].
It is common for AT-hook proteins to function in multiple
processes. The functional duality described above for HMGA1a is
also observed for EBV’s EBNA1 protein, which functions in
replication and transcription activation [13,21]. In S. cerevisiae,
Orc2 is critical to establish transcriptional silencing at the HML
and HMR mating type loci in addition to its replication function
[22,23]. Displacement of AT-hook proteins from bound sequences
can dramatically alter cellular and organismal phenotypes. For
instance, specific displacement of the Drosophila AT-hook protein,
D1, from bound chromosomal AT-rich sequences using a
peptidomimetic agent, or a synthetic AT-hook protein, alters
patterned gene expression programs, position effect variegation,
and development [24,25,26,27]. These studies also indicate that
cell-permeant peptidomimetics directed against specific AT-hook
motifs can profoundly affect cellular function.
Because the distribution of AT-rich sequences within the GC-
rich Leishmania genomes is localized to functional elements such as
SSRs, we hypothesized that AT-hook proteins were likely to be
encoded within the Leishmania genome. We anticipated that if such
proteins were expressed in Leishmania, they would participate in
essential processes such as transcription and DNA replication, and
therefore represent novel targets for therapeutic intervention
against Leishmaniasis.
We mined the L. major genome to identify AT-hook proteins,
and have functionally characterized the L. amazonensis homolog of
the L. major protein encoded by LmjF06.0720, which we have
termed LamAT-Y. We focused on LmjF06.0720 because its
homologs are highly conserved in all sequenced Leishmania sp., but
not the mammalian host, rendering it an excellent candidate target
for therapeutic intervention. Our results indicate that LamAT-Y is
expressed in both promastigote and amastigote stages, and that its
AT-hook domains are functionally equivalent to the AT-hook
domains of HMGA1a. Further, we have used the sequence of
LamAT-Y to design a peptidomimetic that inhibits replication of
promastigotes and intracellular amastigotes without substantive
effects on mammalian cells. We discuss these results in the context
of Leishmania molecular biology, and the rational design of parasite-
selective therapies against Leishmaniasis.
Results
The N-terminal AT-hook domain of the L. major gene
LmjF06.0720 is conserved uniquely in Leishmania species
In light of the functions of AT-hook proteins in other
eukaryotes, and the AT-richness of SSRs, we employed two
strategies to mine the L. major genome to identify candidate
Leishmania AT-hook proteins. In the first of these, we searched for
proteins that contained canonical AT-hooks such as those in
HMGA1a (Table S1), whereas in the second, we used PSI-BLAST
searches to identify sequences of low-complexity that contained at
least three glycine-arginine (GR) or arginine-glycine (RG)
dipeptide repeats (Table S2), which are also known to bind AT-
rich DNA. Six proteins were identified with canonical AT-hooks,
and 21 proteins with at least three GR/RG repeats. One of these
27 proteins was pursued in this study because in addition to a
canonical AT-hook, this protein, LmjF06.0720, also contains two
long GR repeats. LmjF06.0720 also contains a YEATS domain,
which is associated with transcription regulation and chromatin
remodeling [28,29]. LmjF06.0720 is predicted to encode a 1765
amino acids (a.a.) protein and is depicted schematically in
Figure 1A. The amino-terminal 330 a.a. of LmjF06.0720 contains
two extended GR repeats, labeled GR1 and GR2, and one
canonical AT-hook, labeled H. This protein is predicted to contain
a YEATS domain from a.a. 878-999. The GR repeats and AT-
hook of LmjF06.0720 are highly conserved in all Leishmania species
(Figure 1B), including the more distantly related L. braziliensis, yet
absent from all putatively equivalent YEATS domain-containing
proteins in other trypanosomatids. A nuclear localization sequence
(NLS) with the sequence LPIKRKRGRP between is predicted
between a.a. 318-327 [30,31], and contains the canonical AT-
hook. This NLS is conserved in the orthologs of LmjF06.0720 in
other Leishmania sp. (Figure 1B). Algorithms that predict protein
sub-cellular localization indicate LmjF06.0720 to be nuclear or
shuttle between the nucleus and cytoplasm [31,32]. Structural
predictions indicate the amino-terminal ,700 a.a. to be highly
solvent accessible with no predicted structural elements other than
a short alpha-helix and short beta-sheet between a.a. 15-50 [31].
In contrast to the first ,700 a.a., the rest of LmjF06.0720 is
predicted to be highly structured with a large number of beta-
sheets and alpha-helices predicted between a.a. ,900 to the C-
terminus (ibid). These predictions indicate a very high propensity
for multiple alpha-helices between a.a. 1450 to the C-terminus
(ibid). Curiously, this region is also predicted to have severely
decreased solvent accessibility, perhaps indicative of it being
buried with the three-dimensional structure of LmjF06.0720 or
participating in hydrophobic interactions with other proteins.
In this study, we chose to focus on the L. amazonensis homolog of
LmjF06.0720, termed LamAT-Y, because, unlike L. major, L.
amazonensis can be differentiated in vitro into axenic amastigotes
[33,34], permitting evaluation of LamAT-Y in both promastigote
and amastigote stages. In preliminary experiments, we used filter
binding assays that confirmed the GR1 and ATH domains of
LamAT-Y specifically bound AT-rich DNA in vitro (Supplemen-
tary Information Figure S1).
Next, we examined the expression of LamAT-Y in promasti-
gotes and amastigotes. For this, mRNA extracted from promas-
tigotes and axenic amastigotes was subjected to reverse-transcrip-
tase PCR (RT-PCR). This analysis, shown in Figure 1C, indicated
that LamAT-Y is expressed both in promastigotes and axenic
amastigotes at relatively equivalent levels based on the amount of
input RNA in each reaction. As a control, we examined the
expression of P-4 nuclease [35], whose expression is upregulated in
amastigotes (Figure 1C).
Because our attempts to generate polyclonal antisera against
LamAT-Y did not yield antibodies of adequate specificity, we
further characterized the AT-hooks of LamAT-Y by fusing the
amino-terminal 330 a.a. of LamAT-Y to GFP to create the
chimera, LamAT-GFP, depicted in Figure 2A.
LamAT-GFP is a nuclear protein in promastigotes and
amastigotes
A plasmid encoding LamAT-GFP was introduced into L.
amazonensis and maintained under G418 selection. As indicated in
Figure 2B, transfectants expressed a fusion protein of the expected
size as determined using anti-GFP antisera. We examined the
expression of LamAT-GFP relative to GFP at the levels of mRNA
and protein. These analyses, shown in Supplementary Information
Figure S2, indicated that although LamAT-GFP is expressed
equivalently to GFP at the level of mRNA (Figure S2A), the level
of LamAT-GFP protein is expressed at approximately 1.5% the
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e21412Figure 1. Sequence analysis and expression of the predicted N-terminal AT-hook domain of LmjF06.0720 in L. major and its
orthologs in L. amazonensis, L. mexicana, L. infantum, and L. braziliensis. (A) Schematic of the entire open reading frame predicted by
LmjF06.0720. GR indicates Glycine-Arginine dipeptide repeats; ATH denotes the classical RGRP AT-hook motif; YEATS, indicates YEATS protein family
domain. (B) Sequence alignment of the first ,330 amino-acids in LmjF06.0720 and its orthologs in L. amazonensis, L. mexicana, L. infantum and L.
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indicated that the mRNA levels of LamAT-Y are approximately
20% the levels of LamAT-GFP (Figure S2C).
Indirect immunofluorescence, performed using anti-GFP anti-
sera indicated that LamAT-GFP was nuclear in promastigotes
(Figure 2C). Consistent with this localization, fractionation of
promastigotes into nuclear and cytoplasmic fractions indicated
that LamAT-GFP was predominantly localized in the nuclear
fraction (Figure 2D). The localization of histone H3 was used as a
control for this analysis (ibid). Finally, we examined the localization
of LamAT-GFP in non-motile axenic amastigotes using direct
fluorescence microscopy. Here also, LamAT-GFP was observed to
be predominantly nuclear (Figure 2E). We did not observe
LamAT-GFP localizing to kinetoplasts in either amastigotes or
promastigotes (Figures 2C, 2E). These analyses confirm predic-
tions that LamAT contains an NLS, and support the predicted
nuclear localization of LamAT-Y.
Netropsin affects promastigote replication and disrupts
nuclear localization of LamAT-GFP
The actinobacterial oligopeptide netropsin binds AT-rich DNA
with high specificity and affinity [36,37], and consequently
displaces AT-hook proteins from such sequences [38]. Therefore,
we examined its activity against L. amazonensis promastigotes and
determined its effects on the localization of LamAT-GFP.
As shown in Figure 3A, netropsin interfered with the
proliferation of promastigotes in a dose-dependent fashion. At
low doses, such as 10 mM, netropsin had a neglible effect on
proliferation for up to one-week post-addition of the drug. Higher
doses of netropsin severely abrogated promastigote proliferation;
these effects were detected as early as two-days post drug addition.
We examined the effect of netropsin on promastigote DNA
content by propidium iodide (PI) staining of fixed parasites. As
early as 12 hours post-addition, netropsin affected the distribution
of DNA (Figure 3B). The distribution of DNA from untreated cells
Figure 2. LamAT-GFP localizes to the Leishmania nucleus. (A) Schematic of the LamAT-GFP chimera stably expressed in L. amazonensis. (B)
Immunoblot analysis of lysates from LamAT-GFP transfectants and wildtype controls using anti-GFP antisera ab290. Blots were stripped and probed
with anti-LACK antisera as a loading control (C) Parasites were fixed, cytocentrifuged onto slides, immunostained with anti-GFP (ab290), followed by a
Texas Red-conjugated secondary antibody and counterstained with DAPI. Parasites were then visualized at 630X under DIC illumination or by indirect
immunofluorescence. Bars indicate a scale of 10 mm. (D) Immunoblotting was performed on nuclear and cytoplasmic extracts of control and LamAT-
GFP expressing L. amazonensis and probed with antisera against GFP and histone H3, as indicated. (E) Visualization of axenic amastigote forms of L.
amazonensis expressing LamAT-GFP. LamAT-GFP was visualized by direct fluorescence, and nuclei were counterstained with DAPI. Bars indicate a
scale of 10 mm.
doi:10.1371/journal.pone.0021412.g002
braziliensis. GR1, GR2 and ATH are emphasized in red (C) Semi-quantitative analysis of LamAT-Y expression. Total RNA was isolated from L.
amazonensis promastigotes and axenic amastigotes and quantified prior to cDNA synthesis. The cDNAs were then amplified by PCR for 30 cycles with
input amounts of 3, 8 and 25 ng RNA as denoted using LamAT-Y-specific and P4 nuclease-specific primers and analysed by agarose gel
electrophoresis as indicated. Lane 25* indicates PCRs performed with RNA templates that were not reverse-transcribed.
doi:10.1371/journal.pone.0021412.g001
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Treatment with 10 mM netropsin yielded a small sub-G1
population. In addition, the fraction of S-phase cells, between
the 2N and 4N peaks, also increased. Finally, a small increase in
the number of post-S phase 4N cells was also observed. All three
effects were more pronounced with increased netropsin concen-
trations (ibid). These data indicate that netropsin interferes with
completion of S-phase, and with the passage of cells from S to G2,
or post-G2. We examined these effects further using direct
fluorescence for DNA content and indirect immunofluorescence
Figure 3. Pharmacological agents that bind the minor groove of AT-rich DNA inhibit the growth of Leishmania and disrupt the
nuclear localization of LamAT-GFP. (A) L. amazonensis promastigotes were cultured in the presence of the indicated concentrations of netropsin
for up to seven days. Parasite densities are indicated. (B) The effect of netropsin on promastigote DNA content. After treatment of parasite cultures
for 12 hrs with the indicated concentrations of netropsin, parasites were fixed, stained with PI and analysed by flow cytometry to determine DNA
content. The distribution of DNA from control untreated cells into 2N and 4N peaks is indicated by the solid green profile superimposed upon the
netropsin-treated profiles. The percent of total indicates the number of positive events relative to the total number of parasites passed through the
flow cytometer in that run. (C) The effect of netropsin on the localization of LamAT-GFP. Parasites that had been cultured for 48 hr in the indicated
concentrations of netropsin were fixed and cytocentrifuged onto slides. LamAT-GFP was visualized by indirect immunofluorescence as described in
the Methods; nuclei and kinetoplasts were counterstained with DAPI. Bars indicate scale (10 mm).
doi:10.1371/journal.pone.0021412.g003
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indicated concentrations of netropsin (Figure 3C) were fixed,
immunostained for LamAT-GFP, and counterstained with DAPI.
At low concentrations of netropsin (10 mM), LamAT-GFP
remained predominantly nuclear, consistent with minimal effects
of this netropsin level on promastigote growth (Figure 3A). At
higher concentrations of netropsin, we observed large numbers of
shrunken cells or debris. Double-staining using Annexin V and
propidium iodide indicated that the shrunken cells/debris either
resulted from necrosis or late-stage apoptosis (data not shown). In
addition, about 20-50% of the promastigotes displayed an
abnormal morphology. These cells were often multi-flagellated,
and contained more than one nucleus. Therefore, it is likely that
the increase in the 4N and .4N populations (Figure 3B) at higher
netropsin concentrations is due to the accumulation of cells with
two or more nuclei.
Concurrent with these morphological aberrations, we observed
LamAT-GFP to be displaced from the nucleus (Figure 3C),
suggesting that nuclear localization of LamAT-GFP results from
the association of its AT-hooks with nuclear AT-rich DNA. We
interpret the effect of netropsin on normal replication of
promastigotes to indicate that netropsin affects LamAT-Y, other
Leishmania proteins that bind AT-rich DNA, or cellular processes
that require AT-rich DNA.
It is likely that LamAT-Y is essential for Leishmania because our
attempts to make even a haploid knockout were unsuccessful.
Because the absence of antibodies against intact LamAT-Y was a
further technical impediment to dissect the function of this protein
in Leishmania, we chose to do so in mammalian cells using two well-
described properties of HMGA1a and other AT-hook proteins.
The rationale for this approach was based on prior observations
that over-expression of either Leishmania or mammalian histone H1
have indistinguishable effects in mammalian cells [39,40]. Unlike
the other histones, but akin to AT-hook proteins, histone H1
preferentially associates with AT-rich DNA [41,42,43]. For this
reason, we think it is likely that properties displayed by LamAT-Y
in mammalian cells provide some indication of this protein’s
properties in Leishmania.
LamAT confers nuclear localization and punctate mitotic
chromosome association in mammalian cells
We characterized the localization and mitotic chromosome
binding properties of LamAT (Figure 4) using a chimeric protein
containing the DNA binding domain (DBD) of the EBV EBNA1
protein to facilitate further functional studies (Figure 4). Chimeric
proteins, LamAT-DBD, or HMGA1a-DBD, depicted in
Figure 4A, were stably expressed in human 293 cells. As shown
in Figure 4B, both chimeras were expressed at equivalent levels
and were of the expected size. Although it lacks a distinct nuclear
localization sequence (NLS), HMGA1a localizes to the nucleus, a
property observed previously for HMGA1a-DBD by others and
us. As detected by indirect immunofluorescence of intact cells
using a primary antibody against DBD, the LamAT-DBD chimera
was nuclear (Figure 4C). Studies by the groups of Reeves, Laemmli
and others have shown that HMGA1a and other AT-hook
proteins bind eukaryotic mitotic chromosomes with a character-
istic punctate pattern [44,45]. This pattern arises from the
distribution of the AT-queue of AT-rich sequences along a
chromosome, such that some of these sequences are in
uncondensed loops emanating from the chromosome body that
are easily accessed by AT-hook proteins [45,46]. Because these
AT-rich loops stain poorly with DAPI, AT-hook proteins are
observed as punctate dots slightly removed from the body of the
chromosome [19,44,47]. We observed this localization for
LamAT-DBD and HMGA1a-DBD in mitotic chromosome
spreads from 293 cells stalled in mitosis using colcemid
(Figure 4C). Our previously published studies demonstrate that
DBD alone does not associate with mitotic chromosomes [19,47].
These data show that LamAT confers punctate mitotic chromo-
some association to DBD, and this localization is indistinguishable
from that of a bona fide AT-hook protein (HMGA1a) in
mammalian cells. Next, we used a well-characterized assay for
the replication and mitotic partitioning of a stable episomal
plasmid in mammalian cells [48,49,50], used previously for
HMGA1a [47], to functionally characterize LamAT.
LamAT-DBD mediates retention, replication and
partitioning of an episomal plasmid in mammalian cells
The episomal nuclear genome of Epstein-Barr virus (EBV)
undergoes licensed replication and stable partitioning in EBV-
immortalized cells. A single viral protein, termed EBNA1, and a
sequence within the EBV genome, termed oriP, which is bound by
EBNA1, confers both these properties upon the EBV episome.
EBNA1 possesses a C-terminal site-specific DNA binding domain
(DBD) [51], which specifically associates with two sets of sequences
within oriP, termed the family of repeats (FR) and the dyad
symmetry element (DS) [52,53]. The amino-terminal 370 a.a of
EBNA1 contains multiple glycine-arginine (GR) repeats that
closely resemble the repeats in LamAT, and function as AT-
hooks [19]. Previous studies indicate that HMGA1a, or other
proteins that preferentially bind AT-rich DNA, but not proteins
that non-specifically bind chromosomal DNA, can functionally
substitute for the amino-terminal AT-hooks of EBNA1 [47]. In
addition to chromosome binding, the AT-hooks of EBNA1 and
HMGA1a can recruit the cellular origin recognition complex
(ORC) to facilitate licensed replication of EBV episomes or other
plasmids in mammalian cells [13]. These observations led us to test
whether LamAT could functionally substitute for the AT-hooks of
EBNA1 using well-established plasmid maintenance assays
conducted in human cells.
Unlike protist eukaryotes in which mitosis is not accompanied
by dissolution of the nuclear membrane, transfected plasmids are
inherently unstable in mammalian cells. This is illustrated by the
fate of transfected origin-containing plasmids in yeast versus
mammalian cells. In yeast, these plasmids are maintained as
episomes under selection [54]. In contrast, origin-containing
plasmids are unstable in mammalian cells [55,56,57]. Some
mammalian viruses, such as EBV, have developed strategies to
permit maintenance of their genomes as nuclear episomes. EBV’s
genome contains a cis-acting sequence, FR, which permits
episome maintenance, when bound by EBNA1 or HMGA1a-
DBD [47,55,57]. Therefore, we tested whether LamAT-DBD
conferred stability to an FR-containing plasmid as a measure of its
AT-hook function. In this experiment, shown in Figure 5A, an FR-
containing plasmid that expresses luciferase was transfected into
either control 293 cells, or derivatives of these cells that stably
express HMGA1a-DBD or LamAT-DBD. Both luciferase mRNA
[58], and enzymatic activity [59,60] have a short half-life;
therefore, the amount of measured luciferase activity over-time is
proportional to the amount of episomal template remaining in
transfected cells. As seen in Figure 5A, in control 293 cells, the FR-
containing reporter plasmid is lost at a rate close to the dilution
occurring via cell-division. In contrast, for 293 cells stably
expressing HMGA1a-DBD or LamAT-DBD, this reporter was
stable for the duration of the experiment, as indicated by similar
levels of expression maintained for at least one week post-
transfection.
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stable replication of oriP-plasmids by recruiting ORC [13].
Therefore, we tested whether LamAT-DBD would also support
the replication of a transfected oriP-plasmid. In this assay, the oriP-
plasmid was isolated from a dam+ E. coli strain, and is
consequently susceptible to digestion by the restriction endonu-
clease DpnI [56]. Mammalian cells are unable to methylate
adenosines, and therefore the replication of transfected plasmids in
mammalian cells results in the generation of DpnI-resistant
daughter plasmids [56,61]. When evaluated three weeks post-
transfection, LamAT-DBD supported the episomal replication of
an oriP-plasmid as efficiently as HMGA1a-DBD (Figure 5B).
It is known that oriP-plasmids are partitioned non-randomly,
such that in approximately 80-95% of all mitoses, the daughter
plasmids resulting from each parental plasmid are partitioned
equally into the two daughter cells [62,63]. The efficiency of this
distribution can be measured using a colony formation assay
[47,48,49,50]. In these assays, cells transfected with an oriP-
plasmid that also bears a drug-resistance marker are plated as
single cells and evaluated for their capacity to form a puromycin-
resistant colony after three weeks. Previous experiments have
established that HMGA1a-DBD partitions such plasmids indistin-
guishably from EBNA1, and approximately 3-logs over the
partitioning efficiency of DBD alone [19,47]. As shown in
Figure 5C, LamAT-DBD also supported colony formation to the
same extent as HMGA1a-DBD, and approximately 3-logs over
background levels of colonies formed by random chromosomal
insertion of the transfected plasmid. The experiments shown in
Figure 5 reiterate that LamAT behaves similarly to HMGA1a in
these cellular assays for AT-hook function.
A novel peptidomimetic antagonizes LamAT function in
mammalian cells and interferes with Leishmania
replication
Although peptides such as netropsin are broadly effective
against AT-hook proteins, peptidomimetics have been designed
that are effective against a smaller subset of AT-hook proteins by
displacing them from bound sequences [24,25]. These agents
target specific AT-hook proteins based on the number and
distribution of AT-hooks within the protein, which in turn dictate
Figure 4. LamAT associates with eukaryote chromosomes. (A) Schematic representation of LamAT (LamAT-DBD) or HMGA1a (HMGA1a-DBD)
stably expressed in 293 cells as fusions with the DNA-binding domain of EBNA1. (B) Immunoblots of 293 cell lysates expressing LamAT-DBD or
HMGA1a-DBD visualized using anti-DBD antisera. (C) Localization of LamAT-DBD and HMGA1a-DBD in intact 293 cells (left panels) or on mitotic
chromosomes (right panels) visualized by indirect immunofluorescence using anti-DBD antisera. DNA was counterstained with DAPI.
doi:10.1371/journal.pone.0021412.g004
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(GR1, Figure 1A) in the LmjF06.0720/LamAT-Y ortholog from
L. mexicana (a very close relative of L. amazonensis, whose genome
has been sequenced) is unique to this ortholog when compared to
all predicted L. mexicana proteins. Therefore, we designed a D-
peptide based on the sequence of GR1 (Dpep-GR1), specifically
corresponding to a.a 129-146 of LamAT-Y. Because this peptide
lacks L-isomer arginine residues, it cannot be degraded in living
cells. Dpep-GR1 readily entered both mammalian cells and
Leishmania (Figure 6B) consistent with the function of similar
arginine-containing peptides acting as membrane permeable
protein transduction domains [65,66]. The relative specificity of
Dpep-GR1 was tested by examining its ability to disrupt oriP-
plasmid partitioning in mammalian cells mediated by HMGA1a-
DBD and LamAT-DBD. For this, transfected 293 cells were
exposed to 100 mM Dpep-GR1 for two days post-transfection,
prior to being assayed for colony formation. In these assays, Dpep-
GR1 dramatically reduced the ability of LamAT-DBD to support
colony formation, with a minimal effect on HMGA1a-DBD
(Figure 6A). Therefore, at least in mammalian cells, Dpep-GR1 is
selective for LamAT over HMGA1a.
Akin to netropsin, Dpep-GR1 impacted the proliferation of
Leishmania promastigotes in a dose-dependent manner (Figure 6C),
which we interpret to indicate that LamAT-Y or another
Leishmania AT-hook protein/s is required for promastigote
proliferation. We also tested the effects of Dpep-GR1 on the
replication of intracellular amastigotes. RAW264.7 mouse mac-
rophages were infected with GFP-expressing L. amazonensis
promastigotes and passaged 24 hours post-infection, such that
one half of the cells were exposed to 35 mM Dpep-GR1 for 12
days. At this concentration, Dpep-GR1 does not significantly
affect macrophage survival (data not shown, and Table S3).
Infected RAW264.7 cells were visualized by fluorescence micros-
copy, the results or which are shown in Figure 6D. We observed a
small decrease in the percent of GFP-positive cells in the presence
of Dpep-GR1 (Figure 6D), and quantified in Table S3. However,
the fluorescence per cell decreased strikingly (Figure 6D). We
quantified this decrease by measuring changes in relative median
fluorescence intensity (RMFI) after in the presence or absence of
Dpep-GR1. As seen in Figure 6E, there was a sharp decrease in
RMFI when infected cells were exposed to Dpep-GR1 for 12 days.
There are three possible explanations for the sharp decrease in
fluorescence per cell: 1) That Dpep-GR1 selectively kills infected
macrophages but not uninfected macrophages; 2) That Dpep-
GR1 affects the expression of GFP within intracellular amasti-
gotes; or 3) That Dpep-GR1 reduces replication of intracellular
amastigotes, which in turn reduces the fluorescence per cell.
Although we cannot prove that LamAT-Y is the target of Dpep-
GR1 in Leishmania, our data suggest that effective anti-Leishmanials
can be designed by targeting Leishmania AT-hook proteins.
Discussion
While AT-hook proteins are known to have critical roles in both
eukaryote and prokaryote gene expression and DNA replication,
their function has not been studied previously in Leishmania.W e
have identified several putative AT-hook proteins encoded in the
L. major genome, and focused on LmjF06.0720, which is predicted
to contain three AT-hooks and a YEATS domain. Based on the
known functions of these domains, it is predicted that
LmjF06.0720 functions in transcription, DNA replication and/or
chromatin modification. We analysed the L. amazonensis ortholog
of LmjF06.0720, termed LamAT-Y, because L. amazonensis
promastigotes can be differentiated into axenic amastigotes in
vitro. The predicted amino acid sequence of LmjF06.0720 is
conserved in its orthologs found in other sequenced Leishmania sp.
While LmjF06.0720 is conserved in all Leishmania sp., potential
orthologs are absent in other sequenced trypanosomatid and
mammalian genomes. YEATS domains are found in proteins that
modulate chromatin structure and function [28,29]. By possessing
AT-hooks and a YEATS domain, LmjF06.0720 is likely to
modulate chromatin structure at AT-rich chromosomal sequences.
We note that such sequences are present in the SSRs that
punctuate ORF clusters in all Leishmania chromosomes and are
considered to represent sites for transcription initiation [2,3,4].
We have observed LamAT-Y to be expressed in promastigotes
and axenic amastigotes, and have dissected the function of the AT-
hook-containing amino-terminal domain of this protein, termed
Figure 5. LamAT-DBD confers stability, replication and parti-
tioning to plasmids that contain EBV elements bound by DBD.
(A) 293 cells or 293 cells stably expressing either LamAT-DBD or
HMGA1a-DBD were transfected with FR-containing luciferase reporter
plasmid, following which luciferase activity was monitored from 48-
144 hr post-transfection as described in the Methods. (B) 293 cells
stably expressing LamAT-DBD or HMGA1a-DBD were transfected with a
puromycin-expressing replication reporter plasmid that contains EBV’s
oriP element. Plasmid DNA replication was measured as a function of
resistance to digestion by DpnI as described in the Methods. (C)
Partitioning of the puromycin-containing replication reporter plasmid
used in B was assayed as described in the Methods. 10
5 live-transfected
293 cells were selected with puromycin for 3 weeks post plating,
following which colonies were stained by methylene blue and counted
with ImageJ as described previously [19]. The control cells expressed
DBD alone.
doi:10.1371/journal.pone.0021412.g005
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GFP chimera are greatly enriched in nuclear compared to
cytosolic extracts. Indirect immunofluorescence analysis of L.
amazonensis transfectants expressing LamAT-GFP confirmed
nuclear localization properties for LamAT. Further, exposure to
netropsin, a drug that specifically displaces AT-hook domains
from AT-rich DNA, disrupted the nuclear localization of LamAT-
GFP, suggesting that its nuclear localization is dependent on AT-
hook function. Concurrent with the nuclear displacement of
LamAT-GFP and presumably other Leishmania AT-hook proteins,
netropsin showed dose-dependent inhibitory effects on parasite cell
division. Although the kinetoplast genome is highly AT-rich, we
did not detect LamAT-GFP in promastigote or amastigote
kinetoplasts. However, other eukaryotic AT-hook proteins are
known to shuttle between the mitochondria and the nucleus [67],
and our data do not exclude the possibility that LamAT-Y can do
so under certain conditions.
We have used well-characterized assays in mammalian cells to
examine AT-hook dependent properties of LamAT, because
techniques such as examining protein association with metaphase
chromosomes are unavailable in Leishmania. For these studies, we
have exploited the domain structure of EBNA1, a herpesviral
protein that requires AT-hooks for its functions [19]. EBNA1
contains N-terminal AT-hook domains, and a C-terminal DNA
binding domain (DBD) that associates with cognate binding sites
on the EBV genome (ibid). Upon binding these sites, EBNA1
supports the licensed replication and partitioning of EBV episomes
in mammalian cells. We, and others, have shown that these
Figure 6. Treatment of infected macrophages with the Dpep-GR1 peptidomimetic interferes with LamAT-DBD function and
concurrently reduced parasite burden. (A) 293 cells stably expressing either LamAT-DBD or HMGA1a-DBD were transfected with the replication
reporter plasmid described in Figure 5. Transfected cells were treated with 100 mM Dpep-GR1 for two days after plating, and puromycin-resistant
colonies formed were enumerated after 3 weeks. (B) Dpep-GR1 readily enters L. amazonensis promastigotes. Promastigotes were treated with 1 mMo f
FITC-labelled peptide Dpep-GR1 for one hr, washed twice in PBS, cytocentrifuged onto slides and visualized by direct fluorescence. Bars indicate scale
(10 mm). (C) L. amazonensis promastigotes were cultures in the presence of the indicated concentrations of Dpep-GR1 for up to 7 days. Cells were
enumerated daily. (D) Dpep-GR1 reduces parasite burden in infected macrophages. RAW264.7 cells were infected with a L. amazonensis strain that
expresses GFP. Cells were cultured for 12 days in the presence of Dpep-GR1 at the indicated concentrations and monitored by direct fluorescence
and light microscopy. (E) Infected RAW264.7 macrophages described in D were evaluated by flow cytometry for parasite burden by gating for live
GFP-positive cells at 12 days post-transfection. The relative median fluorescence intensity (RMFI) represents the MFI of the treated culture as a
percent of the untreated culture’s MFI.
doi:10.1371/journal.pone.0021412.g006
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Previous studies indicate that the N-terminal AT-hook containing
domain of EBNA1 can be functionally substituted by AT-hook
proteins such as HMGA1a, but not other chromatin-binding or
nuclear proteins [47]. Therefore, we have compared the function
of a LamAT-DBD chimera to the previously characterized
HMGA1a-DBD chimera. Like HMGA1a-DBD (and native
HMGA1a), LamAT-DBD associates with mitotic chromosomes
in a punctate manner. For HMGA1a, it is proposed that such
punctate binding reflects an association with non-condensed AT-
rich sequences in metaphase chromosomes [45,46]. Our findings
are consistent with LamAT also binding such sequences.
In addition to AT-rich DNA, AT-hooks can bind RNA [68],
and more specifically G-quadruplex RNA [13]. This latter
property is necessary for EBNA1, or HMGA1a, to recruit the
cellular origin-binding complex (ORC) to EBV’s licensed DNA
replication origin (ibid). Like EBNA1 or HMGA1a, the Orc1
subunit of ORC also binds G-quadruplex RNA, and therefore it is
posited that ORC is recruited to EBV’s origin via a G-quadruplex
RNA intermediate (ibid). Because we have observed LamAT-DBD
to support stable replication of EBV origin plasmids as efficiently
as HMGA1a-DBD, it is likely that LamAT retains the capacity to
recruit ORC by binding G-quadruplex RNA. LamAT’s capacity
to bind G-quadruplex RNA is potentially very important in
Leishmania because many Leishmania transcripts are highly GC-rich
and contain G runs.
We have used a plasmid replication assay in mammalian cells to
evaluate the function of a peptidomimetic based on the sequence
of the longest GR-repeat in LamAT. This peptidomimetic, Dpep-
GR1, is indicated to be relatively specific because it interferes with
the function of LamAT-DBD, but not HMGA1a-DBD. There-
fore, it is possible that the length of the GR-repeat within an AT-
hook changes the repertoire of the bound AT-rich DNA RNA
sequences. A similar conclusion was drawn from the function of
synthetic proteins containing multiple AT-hooks. Proteins with 10
and 11 AT-hooks, MATH10 and MATH11, had substantially
different effects on chromosome condensation than a protein with
20 AT-hooks, MATH20 [69]. Concordant with this, MATH20,
but not MATH11, suppressed position effect vareigation when
expressed in Drosophila [26]. This latter effect has been ascribed to
MATH20 displacing the naturally occuring Drosophila protein D1,
which also contains multiple AT-hooks, from bound sites [27].
Because Dpep-GR1 showed specificity toward LamAT, we tested
its effects on the growth and proliferation of L. amazonensis
promastigotes and intracellular amastigotes. Dpep-GR1 severely
reduced the replication of Leishmania promastigotes, and reduced
replication of intracellular amastigotes or decreased gene expres-
sion in them. Our findings indicate that AT-hook proteins are
valid therapeutic targets for Leishmaniasis, and that parasite-
selective drugs can be developed against such proteins.
The chromosomal sequences to which LamAT-Y and other
Leishmania AT-hook proteins are bound are unknown. Although
the Leishmania genome is highly GC-rich, there is a skewed
distribution of AT-rich sequences in regions such as the strand-
switch regions (SSRs) [4,5] from which transcription initiates [2,3].
An example of this is seen in the SSR from chromosome 1 that has
been sequenced in 15 Leishmania species [5]. A sequence analysis of
this SSR examining its AT-richness and the distribution of
uninterrupted AT-tracts is shown in Figure S3 and Table S4.
Overall, this SSR is approximately 50% AT-rich, relative to the
40% AT-richness observed of the entire Leishmania genome. This
SSR contains an open reading frame embedded within it
(indicated as a green arrow in Figure S3), which is flanked by
short AT-rich regions indicated by broken or solid red bars in the
figure. Notably, these AT-rich regions are conserved in all 15
SSRs. A statistical analysis examining the distribution of
uninterrupted AT-tracts within the sequence denoted by the solid
red bar in Figure S3 is shown in Table S4. As seen in the table, this
sequence contains a significantly greater number of uninterrupted
AT-tracts of lengths between 3-9 nucleotides when compared to
30 shuffled permutations of the same sequence. A similar
distribution was observed for the AT-rich region denoted by the
broken red bar (data not shown). Therefore, in addition to being
AT-rich, Leishmania SSRs are also enriched for uninterrupted AT-
tracts. Notably, the lengths of these tracts coincide with the length
of AT-rich sequences bound by mammalian AT-hook proteins
[68,70], consistent with the hypothesis that they are bound by
Leishmania AT-hook proteins.
Some eukaryotic AT-hook proteins displace histone H1 from
repressed chromatin, resulting in derepressed chromatin that is
transcriptionally active [42,43,71,72]. Hallmarks of derepressed
chromatin include acetylated histones, particularly H3 and H4.
Because overexpression of histone H1 is repressive in Leishmania
[39,40], and YEATS domains associate with acetylated histone
H3 and H4 to promote gene expression [28,29,73], it is possible
that LamAT-Y uses its AT-hook domains to displace repressive
histone H1 whilst promoting gene expression through interactions
with acetylated H3 and H4. In addition to their function in
transcription, mammalian AT-hook proteins modulate RNA
splicing, licensed DNA replication, and participate in DNA repair
and recombination. Future studies will indicate whether AT-hook
proteins are involved in these critical processes in Leishmania.
In summary, our findings highlight an important role for AT-
hook proteins in Leishmania biology that may involve multiple
processes including gene expression, DNA replication and DNA
repair. As such, they provide impetus for future studies such as
chromatin immunoprecipitation to identify sites bound by
LamAT-Y and other Leishmania AT-hook proteins as a prelude
to elucidating their functions.
Methods
PCR amplification, plasmid constructs, DNA sequencing
and gene expression analysis
The coding sequence for LamAT-Y (5265 bp) was amplified
from L. amazonensis genomic DNA (Text S1). Primers were
chosen based on the sequence of L. major LmjF06.0720 that was
obtained from Genbank (Accession number XM_001680791). A
934 bp sequence from the 59 end of LamAT-Y coding sequence,
corresponding to the first 331 amino-acids, was amplified from the
full-length clone. This fragment, termed LamAT, and included
BamHI and BstXI recognition sites at 59 and 39 ends respectively.
LamAT was used to replace the HMGA1a coding sequence in the
mammalian expression plasmid AGP177 [47], to create the
LamAT-DBD expression plasmid. A LamAT-GFP chimera was
created by ligating amplified LamAT, flanked by BamHI and PacI
recognition sites, to codon optimized GFP from pXG-GFP+. The
ligated chimera was cloned into pXG [76] to create pXG-
LamAT-GFP. Total RNA was isolated from promastigote and
axenic amastigote forms of L. amazonensis using TRIzol reagent
(Invitrogen) according to manufacturer’s instructions. After
quantification, RNA samples were treated with DNAse (TURBO
DNase, Ambion/Applied Biosystems) according to manufacturer’s
protocols then used to template cDNA synthesis using a DyNAmo
cDNA synthesis kit (Finnzymes/New England Biolabs) according
to manufacturer’s directions. cDNAs were amplified from RNA
inputs using primers specific for LamAT-Y and the amastigote-
specific P-4 nuclease [35].
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parasites using the Aurum total RNA extraction system (BioRad),
following which 5 mM of RNA was reverse-transcribed using the
iScript cDNA synthesis kit (BioRad). A series of real-time PCRs
performed using the SsoFAST-EvaGreen system (BioRad),
corresponding to an input of 1, 0.25, 0.0625, and 0.0156 mMo f
total RNA. PCRs were performed in a BioRad CFX384 cycler,
and CFX Manager software was used for data analysis. The
accuracy of PCR was validated by gel electrophoresis of the
amplified products, and thermal denaturation curves. The
amplification conditions used provided a correlation coefficient
for amplification of .0.99. Ct values were determined automat-
ically using CFX manager. Gene expression was quantified using
the DCt method of analysis. The following primers were used for
real-time PCR: GFP-59 (TCTGCACCACCGGCAAGCTG);
GFP-39 (TGGTCGGGGTAGCGGCTGAA); LACK-59 (AGTT-
CCTGCGCGACAGCCAC); LACK-39 (AGTTCCTGCGCGA-
CAGCCAC).
Leishmania culture and transfections
L. amazonensis promastigotes (strain IFLA/BR/67/PH8), kindly
provided by David L. Sacks, were maintained at 27uC in media
199 and antibiotics as previously described [74]. Promastigotes
were transfected with 10 mg of pXGLamAT-GFP or pXG-GFP+
and initially selected in 20 mg/ml G418 as previously described
[75,76]. Cultures of drug resistant parasites were then further
expanded by 1:20 dilutions every five days. G418 concentrations
were doubled at every passage up to a concentration of 300 mg/
ml. Axenic amastigotes were cultured using conditions described
previously [34].
Filter binding assays
Filter binding assays were conducted using peptides corre-
sponding to amino-acids 121-155 of LamAT-Y (SAL-
STSAPGRGRGRGRGRGRGRGGGRGRGGASAAA), and
290-323 (SASGSPLLFTPDGLPIKRKRGRPPKSQQLALSNT).
The synthesized peptides were acetylated at the amino-terminus
and amidated at the carboxy-terminus (Peptide 2.0, Chantilly,
VA). Assays were conducted as described previously [19]. Briefly,
100 ng of
32P-labeled poly(dA-dT) was used as probe in 25 ml
binding reactions that included 1 mg of poly(dA-dC)(dG-dT) as
competitor and 10 pmol of the indicated peptide. Reaction
volumes were raised to 1 ml after 25 minutes at room temperature
and filtered through 0.1 mm Whatman nitrocellulose membranes.
Filters were washed thrice, dried and analyzed by scintillation
counting. Unlabeled poly(dG-dC), poly(dA-dT) and netropsin
were used as competitors. Probes and competitors were purchased
from Sigma.
Netropsin and AT-hook peptidomimetic treatment of L.
amazonensis
For promastigote growth curves, L. amazonensis promastigotes
were cultured at a starting density of 5610
5 cells/ml under
previously established conditions for up to one week. At the time of
inoculation, netropsin (Sigma-Aldrich) was added at a final
concentration of 10, 50 or 100 mM. Aliquots of cells were counted
daily. For indirect immunofluorescence, L. amazonensis promasti-
gotes grown to a density of 5610
6 cells/ml were treated with the
same concentrations of netropsin detailed above for 48 hours. At
this timepoint, the localization of LamAT-GFP was evaluated by
indirect immunofluorescence as described later in this section. Cell
morphology was evaluated by differential interference contrast
microscopy. A peptide corresponding to amino-acids 133–147 of
LamAT was synthesized with D-amino-acids (Peptide 2.0 Inc.,
Chantilly, VA). For some experiments, the peptide was C-
terminally conjugated to FITC. Peptide was incubated with L.
amazonensis promastigotes at concentrations 20, 35 or 50 mM, and
growth was monitored as described above. Peptide uptake was
visualized by direct fluorescence using the FITC-labeled deriva-
tive. The effect of the peptide on amastigote infections of
macrophages was conducted as described below.
Mammalian cell culture and transfections
293 cells (ATCC number CRL-1573) and RAW264.7 mouse
macrophage-like cells (ATCC Number TIB-71) were cultured as
described previously [47,77]. Derivatives of 293 cells were
constructed by infection with retroviral vectors expressing the
HMGA1a-DBD or LamAT-DBD chimeric proteins as described
previously [19,47]. Clones were obtained by G418 selection, and
pooled prior to use. Mammalian cells were transfected as
described previously [49].
Macrophage infections
RAW264.7 macrophages were seeded at a density of 2610
5/ml
and infected at a multiplicity of infection (moi) of 6:1 with L.
amazonensis transfectants containing pXG-GFP+. Following over-
night infection, any unbound parasites were removed by washing
twice with warm (37uC) PBS. Cultures were than incubated at
35uC for 10–15 days in RPMI1640 medium/10% FBS in the
presence or absence of 35 mM peptide. Viable macrophages were
analyzed by fluorescence microscopy to estimate the number of
amastigotes per cell 10–15 days post infection. For increased
accuracy, trypsinized macrophages were subjected to flow
cytometry using a Becton Dickinson FACS Calibur. The percent
of fluorescent macrophages, and the median fluorescence intensity
were recorded.
Immunoblotting
Immunoblotting was performed using standard protocols, as
previously described, using either rabbit polyclonal anti-GFP
(ab290, Abcam, Inc., Cambridge, MA) at a dilution of 1:2000 for
L. amazonensis, or with rabbit polyclonal antibody 2638 against
EBNA1 [78] as a primary antibody. Immunoblots of nuclear and
cytoplasmic fractions, prepared as previously described [79] from
L. amazonensis control and pXGLamAT-GFP transfectants were
probed with anti-GFP and anti-histone H3 (ab12079, Abcam,
Inc., Cambridge, MA) at 1/500. For chemiluminescent detection,
secondary goat anti-rabbit horse-radish peroxidase-conjugate
(ab290 and antibody 2638) and goat anti-mouse horse-radish
peroxidase-conjugate (ab12079) were used at 1:5000.
Evaluation of luciferase expression and plasmid
replication & partitioning
Mammalian cell lines 293/LamAT-DBD or 293/HMGA1a-
DBD were transfected with AGP53, a luciferase expression
plasmid containing FR, and expressing luciferase under the
control of a minimal HSV-1 TK promoter [49]. Luciferase
expression was examined as a function of time as described
previously, under conditions where the transfected cells were
allowed to divide over the course of the experiment [56].
Transfections were normalized using a co-transfected GFP-
expressing plasmid as described previously [49]. To examine
the ability of LamAT-DBD to support licensed replication of an
oriP replicon, plasmid AGP74, described previously [49] was
transfected into 293/LamAT-DBD, or 293/HMGA1a-DBD
cells. 48 hours post-transfection, cells were placed under
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performed on selected cells, and the level of episomal plasmid
AGP74 was evaluated by Southern blot, using previously
described procedures [49]. To evaluate plasmid partitioning,
cells were transfected with AGP74 and plasmid 2145 that
expresses GFP. 48 hours post-transfection, cells were subjected
to flow cytometry to determine the percent of live-transfected
cells (GFP-positive, propidium iodide-negative). 10
5 transfected
cells were plated on 10 cm dishes, and subjected to puromycin
selection for three weeks as described previously [49]. Colonies
were stained with methylene blue, and counted.
Metaphase chromosome spread preparation and
visualization
Metaphase chromosomes were isolated as described previously
[19,47], and visualized by indirect immunofluorescence using
rabbit polyclonal antibody K67.3 that recognizes the DNA-
binding region of EBNA1 as a primary antibody, and an
AlexaFluor488-conjugated anti-rabbit secondary antibody. Chro-
mosomes were counterstained with DAPI. Data was collected
using a Zeiss AxioPhot microscope using a 100X objective, and 30
Z-sections of 0.05 mm each. Z-sections were deconvolved using the
constrained iterative algorithm using Axiovision version 4.6. The
data represents a maximal intensity projection (0u projection of the
deconvolved stack).
Indirect Immunofluorescence to determine sub-cellular
localization
293, 293/LamAT-DBD and 293/HMGA1a-DBD cells were
grown on cover-slips, fixed in 4% formaldehyde, and subjected to
indirect immunofluorescence microscopy as described previously.
The primary antibody used to detect LamAT-DBD and
HMGA1a-DBD was either 2638 or K67.3, and an Alexa-
Fluor488-conjugated secondary antibody was used. Nuclei were
counter-stained with DAPI. L. amazonensis transfectants were
subjected to indirect immunofluoresence as described above for
mammalian cells, with the exception that parasites were grown in
suspension and transferred to slides by cyto-centrifugation (1000
rpm, five minutes). Anti-GFP antibody (ab290) was used as the
primary antibody, and Texas Red-conjugated secondary antibody
was used for detection. DNA counterstaining was performed by
treating with DAPI (0.5 mg/ml) for 90 to 120 seconds followed by
washing with PBS. Image acquisition and processing was
conducted as described for metaphase chromosomes for sub-
cellular localization, with the exception that a 63X objective was
used (NA 1.35).
AT-richness analyses of the Chromosome 1 SSR
Sequences of all 15 SSRs were obtained from GenBank using
the listed accession numbers. To examine AT-richness, sequences
were scored using a matrix in which A or T were scored as 1, while
G or C were scored as -1. The AT-distribution was calculated
using 10 nucleotide tuples and a sliding window of one nucleotide.
For example, using this matrix, a calulated value of 8 for a 10 nt
tuple would indicate 9 A’s or T’s and 1 G or C. The number of
uninterrupted AT-tracts of lengths between 2-10 nucleotides were
calculated from tuples that ranged from 2–10 nucleotides and a
sliding window of one nucleotide. Sequences were shuffled using
Shuffle v1.02 released under GPLv2 by Edward Trager (Univer-
sity of Michigan). Pair-wise comparisons were used to compare the
numbers of uninterrupted AT-tracts in shuffled sequences to
values obtained for the SSR sequence. Statistical significance was
calculated using the Wilcoxon rank-sum test.
Supporting Information
Figure S1 Peptides corresponding to the first GR repeat and
ATH from LamAT-Y bind AT-rich DNA specifically. (A) Peptides
corresponding to amino-acids 121-155, P(121-155), and 290-323,
P(290-323), for LamAT-Y were tested for their ability to bind
poly(dA-dT) in the presence of excess poly(dA-dC)(dG-dT) as
described in the Methods in nitrocellulose filter binding assays. The
maximal binding measured by scintillation counting at saturating
concentrations of each peptide (20 mM) was set at 100%. The
binding curve for each peptide is indicated in the legend. (B) and (C)
A titration of unlabeled poly(dA-dT), but not poly(dG-dC)
effectively competes for the capacity of P(121-155) and P(290-323)
to bind the labeled poly(dA-dT) probe. Competitors were added
after peptide and probe were incubated for 20 minutes at room
temperature. Peptide, probe and competitor were incubated for a
further 10 minutes prior to filter binding. (D) The AT-rich DNA
bindingpeptidenetropsindisplacesP(121-155)andP(290-323)from
bound probe. A titration of netropsin was added after peptide and
probe were incubated for 20 minutes at room temperature.
(TIF)
Figure S2 Expression analysis of LamAT-GFP and LamAT-Y.
(A) mRNA levels of LamAT-GFP relative to the expression of GFP
as evaluated by real-time PCR. Expression of LACK was used to
normalize expression that was calculated by the DDCt method as
described in the Methods section. mRNA levels were quantified in
four independent experiments (B) Relative expression of LamAT-
GFP and GFP proteins. Extracts from untransfected, LamAT-GFP
transfectants and GFP transfectants were examined by immunoblot
using anti-GFP antisera. The number of cell equivalents used in
each lane is indicated below each lane. The asterisk indicates an
unknown Leishmania protein that is detected by the GFP-antisera.
(C) The relative levelsof LamAT 59 mRNA ends detected in control
cells or in LamAT-GFP transfectants evaluated by real-time PCR.
In control, untransfected cells, these primers only detect LamAT-Y
mRNA, while in LamAT-GFP transfectants, both LamAT-Y and
LamAT-GFP transcripts are detected.
(TIF)
Figure S3 Analysis of AT distribution in chromosome 1 SSRs from
15 Leishmania species. The chromosome 1 SSR from L. amazonensis,a n d
14 other Leishmania was analyzed to determine the lengths and
distribution of AT-runs. The AT distribution across the SSR using 10
nttuplesandaslidingwindowof1nt,scoringAorTas1,andGorCas-
1.Thesevalueswerethenplottedasahistogram(xaxis=consecutive10
nttuples;yaxis=scoreforeachtuple).Leishmaniaspeciesrepresentedare
as follows: L. amazonensis (DQ522035), L. aethiopica (DQ522034), L. sp
MAR1/LEM2494 (DQ522036), L. arabica (DQ522037), L. donovani
archibaldi (DQ522038), L. braziliensis (DQ522039), L. donovani
(DQ522040), L. enriettii (DQ522041), L. guyanensis (DQ522042), L.
infantum (DQ522043),L. major(DQ522044), L. peruviana (DQ522045), L.
tarentolae (DQ522046), L. tropica (DQ522047), L. turanica (DQ522048).
(TIF)
Table S1 Identification of AT-hook containing proteins encoded
by the L. major genome.
(PDF)
Table S2 Identification of L. major proteins containing three or
more repeated GR or RG motif.
(PDF)
Table S3 Comparison of the effect of Dpep-GR1 on the number
of macrophages and GFP+ amastigotes under control and Dpep-
GR1 treated conditions.
(PDF)
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uninterrupted AT-tracts in the SSR sequence denoted by the
solid red bar in Figure S2 for L. amazonensis.
(PDF)
Text S1 DNA sequence for LamAT-Y, the L. amazonensis
ortholog of L. major LmjF06.0720.
(PDF)
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